NEW YORK, NY — As the world dons pink for Breast Cancer Awareness Month this October, a global movement is working to ensure that the most critical, terminal stage of the disease is not left in the shadows. On October 13, 2026, more than 325 landmarks across 50 U.S. states and 20 countries will transition from the traditional pink to a triad of teal, green, and pink. This synchronized illumination marks the centerpiece of the #LightUpMBC campaign, an initiative spearheaded by METAvivor Research and Support to bring visibility to Metastatic Breast Cancer (MBC).
While early detection campaigns dominate the public discourse, the reality for those living with Stage 4 disease is often vastly different. With no known cure and a daily death toll that remains staggering, the #LightUpMBC campaign seeks to bridge the gap between awareness and action, funding the rigorous scientific research necessary to transform a terminal diagnosis into a manageable, chronic condition.
Main Facts: A Global Spectrum of Awareness
The #LightUpMBC campaign is a coordinated global effort designed to honor the lives lost to metastatic breast cancer while providing a platform for the estimated hundreds of thousands currently living with the disease. On the evening of October 13—National Metastatic Breast Cancer Awareness Day—iconic structures ranging from One World Trade Center in New York City to the Mactan-Cebu Airport in the Philippines will glow in the specific colors of the MBC movement.
The Symbolism of the Colors
The choice of colors—teal, green, and pink—is deeply intentional. While pink represents the general breast cancer community, it does not fully encapsulate the experience of Stage 4 patients. Teal symbolizes healing and spirituality, while green represents the "triumph of spring over winter" and the renewal of life. Together, these colors signify the unique journey of the metastatic patient: a life lived in the balance of ongoing treatment and the hope for scientific breakthroughs.
LightUpMBC Live: Bridging Science and Art
Complementing the physical illuminations is "#LightUpMBC Live," a virtual broadcast scheduled for 8 p.m. ET / 5 p.m. PT. Hosted by creator Tami Eagle Bowling, an 11-year MBC survivor, and Broadway star Kara Lindsay, the event is designed to be an immersive educational and emotional experience.
The program features a curated blend of:
- Patient Narratives: Real-time stories shared by individuals living with MBC, broadcast directly from the sites of illuminated landmarks.
- Scientific Briefings: Insights from leading oncologists and researchers regarding the current state of Stage 4 clinical trials and therapeutic developments.
- World-Class Performances: Musical contributions from luminaries such as two-time Tony Award winner Victoria Clark, Tony Award nominee Dorian Harewood, and internationally acclaimed actress Christina Bianco.
Chronology: From a Single Bridge to a Global Phenomenon
The scale of the 2026 campaign is a testament to the rapid growth of patient-led advocacy. The movement did not begin in a corporate boardroom, but rather from a personal wish for visibility.
2017: The First Light
The campaign traces its origins back to 2017 at the Memorial Bridge in Portsmouth, New Hampshire. It was the first landmark to ever light specifically for metastatic breast cancer. The inspiration for this gesture was Jessica Moore, a young woman diagnosed with MBC who recognized the stark disconnect between the "pink ribbon" narrative of "survivorship" and her own reality of lifelong treatment.
The Legacy of Jessica Moore
Jessica Moore passed away at the age of 36, but her vision was carried forward by her best friend, Laura Inahara. What began as a local tribute in New Hampshire evolved into a national, and eventually international, campaign. Inahara founded #LightUpMBC to ensure that the "metastatic" part of the breast cancer conversation was no longer a footnote.
2018–2025: Exponential Growth
Over the last nine years, the campaign has expanded from a handful of local bridges to a massive operation involving 195 cities. By 2026, the campaign has raised over $2.7 million for research. The growth of #LightUpMBC mirrors the rising influence of "patient-advocates"—individuals who use their personal health crises to lobby for policy changes and research funding.
Supporting Data: The Stark Reality of Stage 4
To understand the urgency behind the #LightUpMBC campaign, one must look at the epidemiological data surrounding the disease. Metastatic Breast Cancer, also known as Stage 4, occurs when cancer cells break away from the primary tumor in the breast and travel through the lymphatic system or bloodstream to other parts of the body.
Mortality and Incidence
According to data from the National Cancer Institute (SEER program), an estimated 42,670 people in the United States are expected to die from breast cancer in 2026. This equates to approximately 117 deaths every single day. Virtually all of these deaths are the result of metastatic disease.
Key statistics include:
- Metastasis at Diagnosis: Approximately 6% of new breast cancer cases are "de novo" metastatic, meaning the cancer has already spread by the time it is first discovered.
- Recurrence: Roughly 30% of women diagnosed with early-stage breast cancer will eventually see their disease return as metastatic, sometimes decades after their initial successful treatment.
- The Funding Gap: Historically, only a small fraction of all breast cancer research funding (estimated between 7% and 15% globally) is dedicated specifically to the metastatic stage, despite it being the only stage that kills.
The Biological Challenge
MBC is not a static condition. It most commonly migrates to the bones, liver, lungs, or brain. Even when a patient is "stable" or shows "No Evidence of Disease" (NED) on a scan, the cancer remains present at a cellular level. Treatment is continuous and indefinite. Patients often cycle through various lines of therapy—chemotherapy, hormonal therapy, and targeted biologics—until the cancer develops resistance, necessitating a shift to a new, often harsher, regimen.
Official Responses: Voices from the Frontlines
The leadership at METAvivor emphasizes that while awareness is a starting point, the ultimate goal is the funding of science. Unlike many larger breast cancer charities, METAvivor directs 100% of its net proceeds toward research grants specifically for Stage 4.
Dr. Kelly Shanahan’s Perspective
Dr. Kelly Shanahan, the Board President of METAvivor, offers a unique dual perspective as both a physician and a patient. Diagnosed in 2013, she has defied the average survival statistics.
"When I was diagnosed with metastatic breast cancer in 2013, I certainly didn’t think I’d still be here 13 years later," Dr. Shanahan stated. "My hope and the hope of so many others lies in research, and METAvivor-funded research is increasingly important these days. #LightUpMBC is the biggest contributor to this research, and is also a way to bring us together as a community."
The Founder’s Mission
Laura Inahara, the founder of #LightUpMBC, reflects on the exponential growth of her best friend’s legacy. "Jessica hoped to illuminate one local landmark. Today, her legacy helps families around the world shine a light for the people they love, teach patients with MBC how to advocate for themselves, and has now raised over $2.7 million for critical MBC research."
The Role of Advocacy
Tami Eagle Bowling, the campaign director and host of the live stream, highlights the shift in how patients view themselves. Living with MBC for 11 years, Bowling represents a growing cohort of "long-term thrivers" who credit their survival to the very research METAvivor funds. Her role in the campaign is to move the needle from "passive patient" to "active advocate."
Implications: Changing the Trajectory of a Terminal Disease
The implications of the #LightUpMBC campaign extend far beyond a single night of colorful lights. It represents a fundamental shift in the oncology landscape and the sociology of cancer.
From Terminal to Chronic
The ultimate mission of METAvivor is to transform MBC from a terminal disease into a survivable, chronic condition. By funding research that specifically targets the mechanisms of metastasis—how cells migrate and how they develop resistance to drugs—the organization is helping to extend the "quality of life" for patients. In 2026, the emergence of new antibody-drug conjugates (ADCs) and personalized genomic therapies has provided more "lines of defense" than were available even five years ago.
The Power of the Patient Voice
The #LightUpMBC campaign has forced a re-evaluation of how Breast Cancer Awareness Month is conducted. Corporate sponsors and large-scale NGOs are increasingly being held accountable by the metastatic community, who demand that "awareness" must include the reality of those for whom there is no "cure" or "end of treatment" bell to ring.
Global Solidarity
The inclusion of 20 countries in the 2026 campaign highlights that MBC is a global health crisis. In many parts of the world, access to the latest metastatic treatments is limited by socio-economic factors. By illuminating landmarks like the Ness Bridge in Scotland and various sites in the Philippines, the campaign fosters a sense of global solidarity, pushing for equitable access to life-extending research and care.
A Call to the Public
As the lights go up on October 13, the public is invited to participate not just as spectators, but as witnesses. By photographing these landmarks and sharing them with the hashtags #LightUpMBC and #METAvivor, the campaign leverages social media to create a digital "wall of light." This collective action serves as a reminder to the scientific community and policymakers that while progress has been made, the 117 people lost every day to this disease represent a void that only dedicated, Stage 4-specific research can fill.
For those living with the disease, the sight of a skyscraper or a waterfall glowing in teal, green, and pink is more than a visual spectacle; it is a signal that they are seen, their lives are valued, and the search for a way to live longer continues unabated.
About METAvivor:
METAvivor Research and Support Inc. is a 501(c)(3) nonprofit organization that exclusively funds Stage 4 metastatic breast cancer research. Through a rigorous scientific peer and patient advocate review process, METAvivor awards grants to projects aimed at transforming MBC into a survivable condition. For more information, visit www.metavivor.org.
About #LightUpMBC:
LightUpMBC is a global landmark campaign that occurs annually on October 13. It is dedicated to raising awareness and research funds for metastatic breast cancer. To view the full list of participating landmarks or to donate, visit www.lightupmbc.org.
About the Author
